Panacea Pharmaceuticals, Inc. was founded in 1999 to discover, develop, and commercialize novel therapeutic and diagnostic products for oncology and diseases of the central nervous system. Since its inception, the Company's primary approach to cancer treatment has been immunotherapy and development of companion diagnostics for comprehensive patient management. The Company's lead drug product candidate is a nanoparticle-based therapeutic cancer vaccine that targets a novel patented tumor marker, Human Aspartyl (Asparaginyl) beta-Hydroxylase (HAAH). The company relies on a close collaboration with Brown University where teams of researchers are continuing advances on the Company's core technologies.
Looking for a particular Panacea Pharmaceuticals employee's phone or email?
The Panacea Pharmaceuticals annual revenue was $2 million in 2026.
Rustom Moslem is the Founder and CEO of Panacea Pharmaceuticals.
21 people are employed at Panacea Pharmaceuticals.
Panacea Pharmaceuticals is based in Gaithersburg, Maryland.
The NAICS codes for Panacea Pharmaceuticals are [541711, 5417, 541, 54, 54171].
The SIC codes for Panacea Pharmaceuticals are [28, 283, 2834].